Cartesian Therapeutics Inc. (RNAC) PE Ratio
Cartesian Therapeutics Inc. (RNAC) PE ratio history, current valuation, and earnings analysis. Track price-to-earnings trends in Excel with MarketXLS.
PE Ratio Data
| Period | PE Ratio |
|---|---|
| 2016-12-31 | N/A |
| 2017-12-31 | N/A |
| 2018-12-31 | N/A |
| 2019-12-31 | -5.03 |
| 2020-12-31 | -9.03 |
| 2021-12-31 | -0.93 |
| 2022-12-31 | 0.85 |
| 2023-12-31 | -0.12 |
| 2024-12-31 | -1.37 |
Get Cartesian Therapeutics Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =PERatio("RNAC")
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | RNAC | $6.14 | -2.23% | 0.12M |
| 3 | ||||
| 4 | ||||
| 5 |